4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Neurocrine Biosciences, Inc. (NBIX) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in San Diego, United States with about 2,000 employees. Its market capitalization is roughly $17 billion. In the fiscal year ended 2025-12-31, NBIX reported $2.9B in revenue and $479M in net income.
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.
Interactive charts & full statements → Open the NBIX valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $2.9B | $2.4B | $1.9B | $1.5B | — |
| Gross Profit | $2.8B | $2.3B | $1.8B | $1.5B | — |
| Operating Income (EBIT) | $636M | $583M | $395M | $249M | — |
| Net Income | $479M | $341M | $250M | $154M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $814M | $806M | $795M | $688M | $573M | — |
| Gross Profit | $801M | $788M | $781M | $676M | $563M | — |
| Operating Income (EBIT) | $186M | $228M | $239M | $146M | $24M | — |
| Net Income | $198M | $154M | $210M | $108M | $8M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $4.6B | $3.7B | $3.3B | $2.4B | — |
| Total Liabilities | $1.4B | $1.1B | $1.0B | $661M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NBIX viewer.
About TickerBase · Data methodology & sources